ConductScience.org, home

Gene · 962

Papers3,378

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

181 to 200 of 3,378

Download this page as JSON
TitleJournalYearPMIDFound bySource
CEA cell adhesion molecule 5 enriches functional human hematopoietic stem cells capable of long-term multi-lineage engraftment.iScience202338144459PubTator, text miningPubMed
Systematic analysis based on the cuproptosis-related genes identifies ferredoxin 1 as an immune regulator and therapeutic target for glioblastoma.BMC Cancer202338114959PubTator, text miningPubMed
scNAT: a deep learning method for integrating paired single-cell RNA and T cell receptor sequencing profiles.Genome Biol202338111007PubTator, text miningPubMed
BRD9 determines the cell fate of hematopoietic stem cells by regulating chromatin state.Nat Commun202338102116PubTator, text miningPubMed
Leveraging a KRAS-based signature to predict the prognosis and drug sensitivity of colon cancer and identifying SPINK4 as a new biomarker.Sci Rep202338097680PubTator, text miningPubMed
Killer instincts: natural killer cells as multifactorial cancer immunotherapy.Front Immunol202338090565PubTator, text miningPubMed
In vitro fertilization pregnancy may cause fetal thymic volume involution: A case-control study.Int J Reprod Biomed202338077943PubTator, text miningPubMed
Molecular and temporal control of restimulation-induced cell death (RICD) in T lymphocytes.Front Cell Death202338074985PubTator, text miningPubMed
Identification of SPP1 as a Prognostic Biomarker and Immune Cells Modulator in Urothelial Bladder Cancer: A Bioinformatics Analysis.Cancers (Basel)202338067407PubTator, text miningPubMed
A novel endoplasmic reticulum stress-related lncRNA signature for prognosis prediction and immune response evaluation in Stomach adenocarcinoma.BMC Gastroenterol202338066437PubTator, text miningPubMed
Immunoproteasome function maintains oncogenic gene expression in KMT2A-complex driven leukemia.Mol Cancer202338049829PubTator, text miningPubMed
Chimeric antigen receptor natural killer cells: a promising antitumor immunotherapy.MedComm (2020)202338045827PubTator, text miningPubMed
Optimal combination of MYCN differential gene and cellular senescence gene predicts adverse outcomes in patients with neuroblastoma.Front Immunol202338035110PubTator, text miningPubMed
Identification and validation of disulfidptosis-related gene signatures and their subtype in diabetic nephropathy.Front Genet202338028597PubTator, text miningPubMed
Role of signaling lymphocytic activation molecule family of receptors in the pathogenesis of rheumatoid arthritis: insights and application.Front Pharmacol202338027031PubTator, text miningPubMed
Efficient Iodine Uptake of Ultra Thermally Stable Conjugated Copolymers Bearing Biaceanthrylenyl Moieties and Contorted Aromatic Units Using a [3 + 2] Palladium-Catalyzed Cyclopolymerization Reaction.ACS Omega202338024763PubTator, text miningPubMed
The eighth International Forum on Stem Cells: virtual meeting, October 20-21, 2022.Blood Sci202338023340PubTator, text miningPubMed
Human CD79b+ neutrophils in the blood are associated with early-stage melanoma.Front Immunol202338022639PubTator, text miningPubMed
Identification of A Novel Gene Signature Combining Ferroptosis- and Immunity-Related Genes for Prognostic Prediction, Immunotherapy and Potential Therapeutic Targets in Gastric Cancer.J Cancer202338021154PubTator, text miningPubMed
Identifying prognostic characteristics of m6A-related glycolysis gene and predicting the immune infiltration landscape in bladder cancer.Cancer Cell Int202338017469PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/962/papers?page=10